Friberg Gregory R - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Friberg Gregory R
2026-03-22 21:45:03: ERROR: tag = issuerForeignTradingSymbol , code = 0 , what =
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2026-02-26
Sale
2026-02-26
8:39 pm
BIOMARIN PHARMACEUTICAL INCBMRNFriberg Gregory R
EVP, Chief R&D Officer
6,326$60.38$381,93737,578
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2026-03-16
Option Award
2026-03-18
1:39 pm
2027-03-16
2036-03-15
BIOMARIN PHARMACEUTICAL INCBMRNFriberg Gregory R
EVP, Chief R&D Officer
64,750$0100,699
(Direct)
View
2026-03-17
Tax Withholding
2026-03-18
1:39 pm
N/A
N/A
BIOMARIN PHARMACEUTICAL INCBMRNFriberg Gregory R
EVP, Chief R&D Officer
1,629$56.05100,699
(Direct)
View
2025-10-31
Ownership
2026-02-13
6:54 pm
N/A
N/A
BIOMARIN PHARMACEUTICAL INCBMRNFriberg Gregory R
EVP, Chief R&D Officer
398$45.5343,904
(Direct)
View
2025-09-30
Tax Withholding
2025-10-02
4:33 pm
N/A
N/A
BIOMARIN PHARMACEUTICAL INCBMRNFriberg Gregory R
EVP, Chief R&D Officer
3,304$54.1643,506
(Direct)
View
2025-03-17
Option Award
2025-03-18
6:23 pm
2026-03-17
2035-03-16
BIOMARIN PHARMACEUTICAL INCBMRNFriberg Gregory R
EVP, Chief R&D Officer
58,920$087,980
(Direct)
View
2024-09-30
Option Award
2024-10-01
4:51 pm
2025-09-30
2034-09-29
BIOMARIN PHARMACEUTICAL INCBMRNFriberg Gregory R
EVP, Chief R&D Officer
78,910$078,910
(Direct)
View